Prevalence of vertebral fractures and their prognostic significance in the survival in patients with chronic kidney disease stages 3-5 not on dialysis

The prevalence of vertebral fractures (VF) and their association with clinical risk factors and outcomes are poorly documented in chronic kidney disease (CKD) cohorts. The aim of the study was to evaluate the prevalence of VF in patients with non-dialysis dependent CKD (NDD-CKD), their value in predicting mortality and its correlation with parameters of bone mineral metabolism and vascular calcification. 612 NDD 3-5 stage CKD patients participating in the OSERCE-2 study, a prospective, multicenter, cohort study, were prospectively evaluated and categorized into two groups according to presence or absence of VF at enrollment. VF were assessed with lateral radiographs and Genant semi-quantitative method was applied. Three radiologists specialized in musculoskeletal radiology performed consensual reading of individual images obtained using a Raim DICOM Viewer and a Canon EOS 350 camera to measure with Java Image software in those who had traditional acetate X-ray. Factors related to VF were assessed by logistic regression analysis. Association between VF and death over a 3-year follow-up was assessed by Kaplan-Meier survival curves and Cox-proportional hazard models. VF were detected in 110patients(18%). Serumphosphatelevels(OR0.719,95%CI0.532to0.972,p = 0.032),ankle-brachial index 3 and serum phosphate, the presence of VF (HR 1.983, 95% CI 1.009-3.898, p = 0.047) were an independent predictor of all-cause mortality. In our study 18% of patients with NDD-CKD have VF. Factors associated with VF were age, low serum phosphate levels and peripheral vascular disease. The presence of VF was an independent risk factor for mortality in stages 3-5 NDD-CKD patients. Clinical trials are needed to confirm whether this relationship is causal and reversible with treatment for osteoporosis

HIV in Spain 2017: policies for a new management of chronicity beyond virological control

The analysis of the available databases related to HIV/AIDS confirms a paradigm shift in the patient's life expectancy: now HIV has become a chronic disease, so patients are aging. However, this advance is accompanied by a negative counterpart: due to the increase in the number of years of life gained, there is a prevalence of comorbidities greater than the general population and at an earlier age. Reducing the risk associated with all the comorbidities that the ageing patient with HIV/AIDS may develop, must now be a health objective; it must be added to the traditional objectives that until now were part of the strategy to reduce the impact of the HIV infection. In the specific case of women, it is also necessary to train peri and postmenopausal women to increase their skills and motivation to care for their health; It is also very important to examine the role that hormone replacement therapy can play in reducing their symptoms.El análisis de las bases de datos disponibles relacionadas con VIH/SIDA confirma un cambio de paradigma en la esperanza de vida del pa-ciente: ahora el VIH se ha convertido en una enfermedad crónica, con la que los pacientes están envejeciendo. No obstante, este avance se acompaña de una contraparte negativa: debido al incremento en el número de años de vida ganados, se da una prevalencia de comorbilidades mayor a la de la población general y a una edad más temprana. Reducir el riesgo asociado a todas las comorbilidades que puede desarrollar el paciente con VIH/SIDA mientras envejece debe ser hoy en día un objetivo de salud, que se suma a los objetivos tradicionales que hasta ahora formaban parte de la estrategia para reducir el impacto de la infección por el VIH. En el caso específico de la mujer, además es necesario formar a las mujeres peri y postmenopáusi-cas para incrementar sus habilidades y su motivación para el cuidado de su salud; también es muy importante que se examine el rol que puede tener la terapia de reemplazo hormonal en la reducción de sus síntomas. Palabras clave: VIH, SIDA, Comorbilidad, Cronicidad, Envejeci-miento, Política sanitaria, Gestión clínicaEl presente trabajo ha sido editado por la Fundación Gaspar Casal, con ayuda del patrocinio de Gilead Sciences.S

[La pequeña (Barcelona.1992)]

Bibliografía: p. 9Copia digital. España : Ministerio de Cultura y Deporte. Subdirección General de Cooperación Bibliotecari

Overview of the European Upper Palaeolithic : the Homo sapiens bone record

Altres ajuts: acords transformatius de la UABThe European Upper Palaeolithic represents a period of special relevance during which anatomically modern human (Homo sapiens) populations arrive and radiate throughout the continent, while Neanderthals are gradually assimilated. The territorial and demographic expansion of anatomically modern humans (AMH) into new areas that took place during this period and the increase in funerary ritual resulted in a numerous collection of well-preserved human remains previously unseen in Europe. This skeletal record complements the archaeological and environmental data, and allows the development of hypotheses about biological and cultural processes in Late Pleistocene populations. We conducted an extensive compilation of most of the Homo sapiens fossils documented in European Upper Palaeolithic chronologies to date with the aim to explore the palaeoanthropological record and their archaeological context. The database created in this study shows a considerably extensive record of uneven quality accumulated since the mid-19th century that reveals a progressive advance and consolidation of modern human populations in western Eurasia since 45,000 BP. Our results show that the Early Upper Palaeolithic record is dominated by isolated and disarticulated remains. With the onset of the Full phase of the Upper Palaeolithic, there was a considerable increase in skeletal remains and the expansion of funerary practices throughout Europe. Despite population contractions during the Last Glacial Maximum event, the human bone record is slightly larger in the Final phase of the Upper Palaeolithic

VIH en España 2017: políticas para una nueva gestión de la cronicidad más allá del control virológico

El análisis de las bases de datos disponibles relacionadas con VIH/SIDA confirma un cambio de paradigma en la esperanza de vida del paciente: ahora el VIH se ha convertido en una enfermedad crónica, con la que los pacientes están envejeciendo. No obstante, este avance se acompaña de una contraparte negativa: debido al incremento en el número de años de vida ganados, se da una prevalencia de comorbilidades mayor a la de la población general y a una edad más temprana. Reducir el riesgo asociado a todas las comorbilidades que puede desarrollar el paciente con VIH/SIDA mientras envejece debe ser hoy en día un objetivo de salud, que se suma a los objetivos tradicionales que hasta ahora formaban parte de la estrategia para reducir el impacto de la infección por el VIH. En el caso específico de la mujer, además es necesario formar a las mujeres peri y postmenopáusicas para incrementar sus habilidades y su motivación para el cuidado de su salud; también es muy importante que se examine el rol que puede tener la terapia de reemplazo hormonal en la reducción de sus síntomas